TGFB1 and systemic sclerosis: Overall, these data suggest that canonical ALK5/Smad signalling is likely to contribute to but not be the fundamental basis of the persistent fibrotic phenotype of lesional SSc fibroblasts and suggest that blocking non-canonical TGFβ pathways may be a better alternative in combating the persistent fibrotic phenotype in SSc [12,13].